This study is a randomized controlled trial comparing two minimally invasive surgeries-laparoscopic lateral suspension and laparoscopic sacrocolporopexy-for women who develop vaginal cuff prolapse after hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses support after the uterus is removed, which can cause discomfort, bulging, or urinary and bowel problems. The goal of this study is to determine which surgical approach is safer, more effective, and improves quality of life for patients. Women enrolled in the trial will be randomly assigned to one of the two surgeries, and outcomes such as prolapse recurrence, complications, recovery time, and patient satisfaction will be carefully monitored. By comparing these two techniques, this study aims to provide clear guidance for surgeons and patients to make informed decisions about the best surgical treatment for post-hysterectomy vaginal cuff prolapse.
This study is a randomized controlled trial (RCT) designed to compare the outcomes of two minimally invasive surgical techniques-laparoscopic lateral suspension and laparoscopic sacrocolpopexy-for the treatment of vaginal cuff prolapse following hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses its normal support after the uterus has been removed, leading to symptoms such as a sensation of vaginal bulging, pelvic pressure, urinary or bowel dysfunction, and discomfort during daily activities or sexual intercourse. Eligible participants are women who have previously undergone hysterectomy and are experiencing symptomatic vaginal cuff prolapse. Participants will be randomly assigned to undergo either laparoscopic lateral suspension or laparoscopic sacrocolpopexy. Both procedures are performed using minimally invasive laparoscopic techniques, which typically result in smaller incisions, less pain, and faster recovery compared to traditional open surgery. The study will assess multiple clinical and patient-reported outcomes, including: Anatomical success: Prevention of prolapse recurrence at follow-up visits. Functional outcomes: Improvement in urinary, bowel, and sexual function. Complications: Intraoperative and postoperative adverse events. Recovery metrics: Length of hospital stay, return to daily activities, and postoperative pain. Patient satisfaction: Quality of life and overall satisfaction with the procedure. By conducting this study, researchers aim to provide evidence-based guidance on which surgical approach offers better long-term outcomes, fewer complications, and higher patient satisfaction. The results of this trial may help clinicians make informed decisions and improve the care of women with post-hysterectomy vaginal cuff prolapse.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
50
Participants in this arm will undergo laparoscopic lateral suspension for post-hysterectomy vaginal cuff prolapse. The procedure involves attaching a synthetic mesh from the vaginal cuff to the lateral abdominal wall to provide support and restore normal vaginal anatomy. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.
Participants in this arm will undergo laparoscopic sacrohysteropexy for post-hysterectomy vaginal cuff prolapse. The procedure involves suspending the vaginal cuff to the sacral promontory using a synthetic mesh, restoring vaginal support. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.
Basaksehir Cam and Sakura City Hospital
Istanbul, Istanbul, Turkey (Türkiye)
RECRUITINGAnatomical Success (Point C of POP-Q System)
Vaginal cuff support measured objectively using POP-Q system, focusing on point C (position of the vaginal apex relative to the hymen). Success is defined as point C remaining above the hymen at follow-up by a blinded examiner.
Time frame: 12 months post-surgery
Operative Time
Total duration of the surgery measured in minutes from incision to closure.
Time frame: During surgery
Postoperative Hospital Stay
Length of hospital stay in days from surgery to discharge.
Time frame: From the day of surgery through hospital discharge (an expected average of 2 days)
Postoperative Complications
Includes mesh exposure, infection, bleeding, urinary or bowel injury, and reoperation.
Time frame: Up to 12 months post-surgery
Pelvic Floor Distress Inventory (PFDI-20)
Patient-reported measure of prolapse, urinary, and bowel symptoms. The PFDI-20 consists of 3 subscales: Pelvic Organ Prolapse Distress Inventory (POPDI-6) Colorectal-Anal Distress Inventory (CRADI-8) Urinary Distress Inventory (UDI-6) Each subscale is scored 0-100, and the total score is the sum of the three subscales (0-300). 0 = no pelvic floor-related distress at all. 300 = the maximum possible distress, meaning the respondent endorsed the highest level of bother on all 20 items.
Time frame: Preoperative and 12 months post-surgery
Pelvic Floor Impact Questionnaire (PFIQ-7)
Patient-reported measure of the impact of pelvic floor disorders on daily activities, relationships, and quality of life. The PFIQ-7 includes 3 subscales: Urinary Impact Questionnaire (UIQ-7) Colorectal-Anal Impact Questionnaire (CRAIQ-7) Pelvic Organ Prolapse Impact Questionnaire (POPIQ-7) Each subscale contains items scored 0-3 ("not at all" to "quite a bit"), then converted to a 0-100 scale. The three subscales are summed for a total score ranging from 0 to 300. 0 = no impact on quality of life. 300 = maximum impact across all domains (urinary, colorectal-anal, and prolapse). Higher scores indicate worse quality-of-life impairment due to pelvic floor disorders.
Time frame: Preoperative and 12 months post-surgery
Patient Global Impression (PGI) Scale
Patient-reported scale evaluating overall improvement or satisfaction with surgery, typically rated from 1 ("very much improved") to 7 ("very much worse").
Time frame: Preoperative and 12 months post-surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.